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Background: HIV-1 Nef is a multifunctional protein required for full pathogenicity of the virus. As Nef has no
known enzymatic activity, it necessarily functions through protein-protein interaction interfaces. A critical Nef
protein interaction interface is centered on its polyproline segment (P69VRPQVPLRP78) which contains the helical
SH3 domain binding protein motif, PXXPXR. We hypothesized that any Nef-SH3 domain interactions would be lost
upon mutation of the prolines or arginine of PXXPXR. Further, mutation of the non-motif “X” residues, (Q73, V74,
and L75) would give altered patterns of inhibition for different Nef/SH3 domain protein interactions.
Results: We found that mutations of either of the prolines or the arginine of PXXPXR are defective for Nef-Hck
binding, Nef/activated PAK2 complex formation and enhancement of virion infectivity (EVI). Mutation of the
non-motif “X” residues (Q, V and L) gave similar patterns of inhibition for Nef/activated PAK2 complex formation
and EVI which were distinct from the pattern for Hck binding. These results implicate an SH3 domain containing
protein other than Hck for Nef/activated PAK2 complex formation and EVI. We have also mutated Nef residues at
the N-and C-terminal ends of the polyproline segment to explore interactions outside of PXXPXR. We discovered a
new locus GFP/F (G67, F68, P69 and F90) that is required for Nef/activated PAK2 complex formation and EVI.
MHC Class I (MHCI) downregulation was only partially inhibited by mutating the PXXPXR motif residues, but was
fully inhibited by mutating the C-terminal P78. Further, we observed that MHCI downregulation strictly requires G67
and F68. Our mutational analysis confirms the recently reported structure of the complex between Nef, AP-1 μ1 and
the cytoplasmic tail of MHCI, but does not support involvement of an SH3 domain protein in MHCI
downregulation.
Conclusion: Nef has evolved to be dependent on interactions with multiple SH3 domain proteins. To the N- and
C- terminal sides of the polyproline helix are multifunctional protein interaction sites. The polyproline segment is
also adapted to downregulate MHCI with a non-canonical binding surface. Our results demonstrate that Nef
polyproline helix is highly adapted to directly interact with multiple host cell proteins.
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HIV-1 Nef is a highly significant pathogenic factor, but
its role in the progression to AIDS is not mechanistically
understood. Nef is remarkable in the number and diver-
sity of its functions, and its pathogenicity may depend
on the collective impact of its highly conserved multiple
activities [1,2]. Among its numerous activities, Nef
downregulates major histocompatibility complex class I
(MHCI) from the cell surface, downregulates CD4, acti-
vates and forms a complex with p21-activated protein
kinase 2 (PAK2) and enhances the infectivity of the
HIV-1 virion [2,3]. It is plausible that each of these four
Nef functions makes contributions to HIV-1 Nef patho-
genicity. Nef/activated PAK2 complex formation may
enhance cellular activation and, as a result, viral replica-
tion [4]. MHCI downregulation appears to blunt the
host cytotoxic T cell response to the virus [5-7]. CD4
downregulation may enhance the efficiency of viral pro-
duction [8-10]. Finally, enhancement of virion infectivity
(EVI) may facilitate the spread of the virus throughout
the infected patient [11].
Nef downregulates or upregulates a large number of
cell surface receptors, though it has recently been sug-
gested that the mechanism of modulating the levels of
many of these proteins is indirect [12,13]. The mechan-
isms of these indirect effects are, in general, unknown;
and ultimately Nef must directly interact with host cell
proteins as it has no enzymatic activity [2]. Here, we
have studied Nef activities that appear to depend on dir-
ect interactions between Nef and relevant host cell target
proteins. These activities include CD4 and MHCI down-
regulation, as direct binding of Nef to the cytoplasmic
tails of these membrane proteins has been demonstrated
[14-19]. Also, direct roles for SH3 domain proteins have
been suggested for several Nef activities: 1) the SH3 do-
main protein, Hck, is known to bind Nef with nM affinity
[20]; 2) Activation of Hck and other Src family kinases has
been proposed to facilitate MHCI downregulation by for-
mation of a Nef/Src family kinase/ ZAP70/PI3K complex
[21,22]; 3) The activation of PAK2 and the formation of
the Nef/activated PAK2 complex appear to require an
SH3 domain protein [20]. Finally, mutational evidence
suggests the involvement of an SH3 domain containing
protein for EVI [2].
To begin to unravel the complex interactions between
Nef and the multiple host cell proteins involved in these
Nef activities, we have used fine structure mutational ana-
lysis to describe the roles of the polyproline segment,
P69VRPQVPLRP78, residues. First, we mutated each residue
of the core sequence, PQVPLR, that represents the Nef
SH3 domain binding motif (PXXPXR) [23,24]. Our analysis
confirmed the importance of the prolines and established
the significance of the arginine in the Nef PXXPXR SH3
domain binding motif [20]. The remaining three residues(X’s) were expected to contribute to the specificity of bind-
ing for a particular Nef/SH3 domain pair [25-28].
We also searched for functionally significant residues near
PQVPLR that could be necessary for Nef/activated PAK2
complex formation, MHCI downregulation, and EVI. Two
residues to the N-terminal side P69VRPQVPLRP78, G67
and F68, were found to be critical for Nef/activated PAK2
complex formation, EVI and MHCI downregulation. Based
on our mapping analysis, we have proposed a new multi-
functional Nef-host cell protein interface for these activities.
To the C-terminal side of PXXPXR, we also characterized
the functional significance of P78. In contrast to mutations
of PXXPXR, G67 and F68, the phenotype of the P78 mutant
was not multiply defective but specific for MHCI downre-
gulation. This result suggests a unique mechanism inde-
pendent of Nef interacting with an SH3 domain protein.
With the current data, we and others have now character-
ized the dependence of MHCI downregulation on the
stretch of Nef amino acids from E62 to P78 plus the D123
residue that is spatially near P78 [29-33]. These results con-
firm in detail the recently reported structure for the tripar-
tite complex formed by Nef, AP-1 μ1, and the cytoplasmic
tail of MHCI downregulation [34]. Our new results greatly
expand the understanding of the polyproline segment, and
represent the first advance in integrating Nef structure and
function.
Results
SH3 domain protein involvement in three Nef activities
The identities of the putative SH3 domain proteins neces-
sary for Nef/activated PAK2 complex formation, MHCI
downregulation, and EVI are not known: therefore, the
Nef-SH3 domain interactions could only be assessed by
functional assays. The three assays were all performed with
intact cells which make analysis of the Nef-SH3 domain
interaction more difficult to interpret. However, if a direct
interaction with an SH3 domain protein is mechanistically
required for a given Nef activity, then all three of the point
mutations of the prolines and the arginine in PXXPXR
should eliminate the activity. If Nef binds multiple SH3 do-
main proteins, the mutation of the remaining residues
PQVPLR, should distinguish between different SH3 do-
main proteins. Therefore, we have used the requirement
that single mutations of both prolines and the arginine are
fully defective before concluding that there is a Nef-SH3
domain interaction involved. Conservative mutations of
the other three residues of PXXPXR then distinguish
between different SH3 proteins that bind Nef [25-27].
The polyproline helix
We began our investigation of Nef effector interfaces by
assaying Nef-Hck SH3 domain binding in vitro. The results
of these direct binding assays can then be used to evaluate
subsequent results of functional assays. The importance of
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been demonstrated for Nef-Hck SH3 domain binding with
the mutations, P72A and P75A, but R77 has not been ad-
equately tested [20]. Here, we have used mutations P72G,
P75G and R77K. For the other three residues, we mutated
Q73 to R, V74 to I, and L76 to V. All of the residues in
PQVPLR are very highly conserved (HIV-1 subtype B data
base of 1643 sequences, >97% [32]); therefore, even con-
servative amino acid replacements (as defined by BLO-
SUM62, [35]) are expected to disrupt of at least one
important Nef function. Summarizing, it is expected that
the one to one binding of Nef to the Hck SH3 domain will
give structurally interpretable information needed to evalu-
ate functional assays.
Nef-Hck SH3 interaction
The ability of the eight singly mutated Nefs to bind to
the Hck SH3 domain in direct binding assays is pre-
sented in Figure 1. Four of the mutations, P72G, V74I,
P75G and R77K each gave no evidence of binding in pull
down assays. The results are consistent with X-ray crys-
tal data that P72, P75, and V74 engage in extensive hydro-
phobic interactions between wild type Nef and the
planar hydrophobic surface of the SH3 domain [23,24].
The loss of binding by R77K also reflects the multiple
interactions between R77 and Hck SH3 residues [23,24].
Conservative mutations of the residues, Q73 and L76,
which do not strongly interact with Hck SH3 domain
residues in the crystal structure, did not reduce binding
to Hck [23,24]. The disruption of binding by V74I and
R77K validates the use of conservative mutations to de-
fine Nef interactions with SH3 domain proteins.
Two additional mutations were made to further
characterize Nef binding to Hck. In X-ray crystal struc-
tures, P78 is predicted to bend away from the planar
hydrophobic interface of the Hck SH3; and therefore it
defines the border of the core SH3 domain binding siteFigure 1 In vitro binding to the SH3 domain of ht-HckSH3 by SF2Nef
were incubated with the Hck SH3 domain at 3 μM each. The extent of Hck
described [29]. Upper Panel, Bound His-tagged-Hck SH3 domain protein (ht
antibody. After GST-F90A, a lane was skipped and 20% of the amount of h
lane. Lower Panel, Equal amounts of GST and GST fusion proteins were add
Coomassie Blue staining.[23,24]. As expected, the P78G mutation has minimal im-
pact on Nef-Hck SH3 domain binding. Nef also interacts
with the RT loop of the Hck SH3 domain which is outside
of the SH3 planar hydrophobic interface [24,36,37]. An
isoleucine in the Hck RT loop is buried in a hydrophobic
pocket on the surface of Nef formed by L87, F90, W113,
I114, T117 and Q118 [23,24,38]. Unexpectedly, we found no
reduction in binding by the non-conservative F90A muta-
tion (Figure 1). The simplest explanation is that the
remaining residues in the pocket are sufficient to stabilize
the Nef-Hck SH3 interaction. With these eight mutations,
we have a Nef-Hck SH3 domain interaction signature to
compare with other Nef activities.
Nef-SH3 domain interaction required for Nef/activated
PAK2 complex formation
Having established a basis for comparing putative Nef
SH3 interactions to Nef-Hck SH3 binding, we investi-
gated the role of PQVPLR in Nef/activated PAK2 com-
plex formation. In extracts from cells not expressing
Nef, PAK2 autophosphorylation is not detectable by the
sensitive in vitro kinase activity assay (IVKA) using anti-
PAK2 antibody. IVKAs of extracts from cells expressing
Nef exhibit both PAK2 autophosphorylation and phos-
phorylation of the added substrate myelin basic protein
(Additional file 1: Figures S1A and S1B). We have previ-
ously demonstrated that in Nef-expressing cells only a
small fraction of activated PAK2 is not immunoprecipi-
tated by anti-Nef antibody and that the activation of
PAK2 by Nef is sufficient to alter the phosphorylation
state of an intracellular protein [39,40]. The components
of the Nef/activated PAK2 complex have not been iden-
tified leaving open the possibility that the activation of
PAK2 by Nef could be a multi-step process with activa-
tion separate from complex formation.
To demonstrate a role for an SH3 domain protein in
Nef/activated PAK2 complex formation, it is necessary forand SF2Nef mutants. Purified GST and GST-SF2Nef fusion proteins
binding to GST or GST-SF2 fusion proteins was assayed as previously
-HckSH3) was determined by Western blot analysis with anti-His tag
t-HckSH3 was added to the binding reactions and was run in the last
ed to the binding assays as shown by SDS/PAGE followed by
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PXXPXR to abrogate this activity as was observed for Hck
binding. It has been previously shown that Nefs with P72A
or P75A mutations fail to form the Nef/activated PAK2
complex which suggests SH3 protein involvement [20,41].
However, this suggestion would be called into question if
Nef with the R77K mutation gave a functional phenotype.
Mutations of the other residues in PQVPLR (Q, V, and L)
should give a different mutational profile for Nef/activated
PAK2 complex formation compared to Hck (Figure 1).
In Figure 2A, evidence is presented that confirms a
role for an SH3 domain protein for Nef/activated PAK2BA
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Figure 2 Mutational analysis of the HIV-1 Nef-SH3 interaction domain
autophosphorylation assay of anti-Nef immunoprecipitates from transfected
band, indicated by the arrow. Higher molecular weight bands that are wea
PAK2 complex [43]. Control represents transfected 293T cells without Nef e
demonstrates equal Nef expression in transfected cells. Lower Panel, Phosph
Error bars were calculated as the mean ± S.E.M. of three independent expe
SF2Nef by t test (p< 0.05). SF2NefV74I and SF2NefP78G are not significantl
(B), Upper Panel, flow cytometric analysis of SF2Nef transduced human CEM
was determined as described in Methods. Control represents CEM cells tran
downregulation relative to SF2Nef is presented. SF2Nef, n = 6, is set at 100%
= 4; V74I, n = 4; P75G, n = 6; L76V, n = 4, R77K, n = 4; P78G, n = 3; F90A, n =
(p< 0.05). Only P78G is not significantly higher than control by t test.complex formation. Mutations of the canonical residues
of PXXPXR abrogate this Nef activity as was observed
for Hck SH3 binding. Strikingly different from the Nef-
Hck SH3 domain interaction is the failure of V74I to
prevent Nef/activated PAK2 complex formation, and
conversely, the elimination of Nef/activated PAK2 com-
plex formation; by Q73R. Thus, conservative mutations
of the residues in PQVPLR allow discrimination of the
SH3 domain interactions between Nef-Hck and between
Nef and the unknown SH3 domain protein required for
Nef/activated PAK2 complex formation. L76V, and pos-
sibly P78G, have a small negative effect on Nef/activatedMHCI Downregulation
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: PQVPLR, P78, and F90. (A), Upper Panel, in vitro PAK2
293T cells. Autoradiography shows the autophosphorylated PAK2
kly phosphorylated are proteins associated with the Nef/activated
xpression. Middle Panel, Anti-Nef Western blot of whole cell lysates
oimager quantitation of activated PAK2 relative to SF2Nef set at 100%.
riments. An asterisk indicates a significantly lower value compared to
y different from SF2Nef by t test (p = 0.065 and p = 0.065, respectively).
T cells. The cell surface expression of CD4 (x-axis) and MHCI (y-axis)
sduced without Nef expression. Lower Panel, Quantitation of MHCI
. Error bars were calculated as the mean ± S.E.M. P72G, n = 6; Q73R, n
3. An asterisk indicates a significantly lower value from SF2Nef by t test
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Hck SH3 binding, F90A eliminated it. The drastic effect
caused by the F90A mutation suggests an alternate role
for F90 distinct from its role as part of the hydrophobic
pocket that interacts with the Hck SH3 RT loop. From
these observations, we have demonstrated that PQVPLR
binds at least two cellular SH3 domain proteins with the
canonical residues in PXXPXR. The PXXPXR motif is
present in many different cellular SH3 domain binding
proteins with different specificities. The non-motif resi-
dues (Q73, V74 and L76 in Nef ) largely determine which
SH3 domain proteins that a particular PXXPXR contain-
ing protein will bind [25,26,28]. While Nef exhibits a
high degree of specificity for Hck because of its high
affinity interaction with Hck, the Nef PXXPXR is also
capable of binding to additional SH3 domain proteins at
reduced affinity [42].
Role of PQVPLR, P78 and F90 in MHCI downregulation
The double mutation of P72 and P75 to alanines
(AQVALR) abrogates the ability of Nef to downregulate
MHCI [44,45]. It was subsequently reported that the sin-
gle mutations, P72A and P75A, are only partially defect-
ive for MHCI downregulation, but the P78A mutation
abolishes this activity [30,33]. Thus, the case can be
made that the double mutation of P72A/P75A yields a
synthetic phenotype that is the result of a local disrup-
tion of Nef structure. In Figure 2B, we evaluated this hy-
pothesis. P72 and P75 mutated to glycine gave partial
defects in MHCI downregulation. Nef with P78 mutated
to glycine was fully defective for MHCI downregulation
(Figure 2B). Significantly, we also demonstrated only a
small effect of the R77K mutation on MHCI downregu-
lation (77.3 ± 5.3% of SF2Nef activity), despite the fact
that this mutation totally prevents Hck binding and Nef/
activated PAK2 complex formation (Figures 1 and 2A).
The L76V and F90A mutations also had partial deficits
for MHCI downregulation (Figure 2B). Therefore, only
the mutation of P78 fully abrogates MHCI downregula-
tion in the polyproline region. Our results are suggestive
of a relatively non-specific structural role for PQVPLR
in MHCI downregulation. CD4 downregulation was also
monitored as a positive control of overall Nef activity
and was fully functional in all cases. Finally, it should be
noted that all the mutations presented in Figure 2 were
stably expressed at levels similar to the wild type protein
(Figure 2A, Middle Panel).
Our results do not support the involvement of an SH3
domain protein in MHCI downregulation but point to
P78 and a nearby residue D123. The Nef mutant with
D123E is devoid of MHCI downregulation activity
[31,32]. The mutational phenotypes of P78 and D123 are
fully consistent with recent proposals of a Nef-induced
multi-protein complex that lacks an SH3 domain proteinand blocks MHCI transport to the cell membrane
[15,18,19,46]. In the Discussion, we review a recent
report of the ternary structure of Nef, the cytoplasmic
tail of MHCI (ctMHCI) and AP-1 μ1 [34] that is in full
accord with the mutational data presented here and pre-
viously published [18,19,29,30,32,33].
Enhancement of virion infectivity (EVI)
Another Nef activity that has been suggested to involve
an SH3 binding protein on the basis of the AQVALR
mutation is EVI [11,47,48]. In Figure 3A, the impact of
the mutations from Figures 1 and 2 on this Nef activity
is presented. Similar to the results for Nef/activated
PAK2 complex formation, P72G, P75G, and R77K, and
F90A were all defective for EVI (≤ 33% of SF2Nef activ-
ity), but the V74I mutation had no effect (Figure 3A).
The L76V mutation of Nef appears to yield partial defects
for EVI and Nef/activated PAK2 complex, while the P78G
mutant exhibits near wild type activity for EVI and Nef/
activated PAK2 complex formation (Figures 2A and 3A).
Only Q73R gives a different result in the two assays. Nef
mutated to Q73R yields no Nef/activated PAK2 complex
but is only 50% defective for EVI (Figures 2A and 3A).
We also observed that in contrast to the results for Nef/
activated PAK2 complex formation in Figure 2, the
impacts of the most debilitating mutations are not
complete for EVI (compare SF2NefP72G, P75G, R77K
and F90A to SF2NefΔXho in Figure 3A). The same re-
sidual EVI activity has been reported for the AQVALR
double mutation [49]. Finally, the eight Nef mutants are
all stable in the context of expression from the SF2 pro-
viral plasmid (Figure 3B). These results suggest that EVI
requires an SH3 domain protein that is the same as
or similar to the SH3 domain protein involved in Nef/
activated PAK2 complex formation.
The N-terminal side of the polyproline helix
The SH3-binding motif in Nef is flanked by prolines
(PVRPQVPLRP, amino acids 69 and 78). On the C-
terminal side, P78 is not part of the Nef interface that
binds to the Hck SH3 domain. On the N-terminal side,
P69 has been found to be dispensable for Nef-Hck binding
and is, like P78, outside of the SH3 binding site of Nef
[20,24]. On the other hand, the P69A mutation has been
shown to render Nef incapable of Nef/activated PAK2
complex formation [20,41]. Based on these earlier results,
we considered the possibility that P69 and additional Nef
residues just to the N-terminal side of P69 constitute an
interface that acts in concert with PQVPLR. Specifically,
V66, G67, and F68 are three highly conserved residues
(99%) that form a loop between the polyproline helix and
the tetra-glutamate segment consisting of amino acids
62–65 [32]. In Figure 4, we determined the impact of mu-
tating each of these loop residues to alanine. Similar to
Figure 3 Mutational analysis of PQVPLR, P78, and F90 for Nef-mediated enhancement of virion infectivity. (A), HeLa-MAGI cells were
infected with HIV-1SF2 and HIV-1SF2 with mutant nefs from Figures 1 and 2. ΔXho represents HIV-1SF2 with its nef rendered non-functional by
filling in the unique XhoI site with Klenow to make a four base insertion. β-galactosidase positive cells were counted 36 hours post-infection. Viral
infectivity (blue cells per ng p24gag normalized to HIV-1SF2) is presented as the mean ± S.E.M. with n = 6. SF2Nef was set at 100%. An asterisk
indicates a significantly lower value compared to SF2Nef by t test (p< 0.05). Also note that values for all mutated proteins were significantly
higher than ΔXho. (B), Lysates from the 293T producer cells for viruses presented in (A) were analyzed for Nef and p24gag (p24) expression by
Western blot. Equal amounts of lysate protein were added to each lane.
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http://www.retrovirology.com/content/9/1/47P69, the adjacent residues, G67 and F68, are required for
Nef/activated PAK2 complex formation while V66 is not
(Figure 4A, Upper Panel). G67 and F68 are also required for
MHCI downregulation, but V66 is not (Figure 4B). How-
ever, there is a clear distinction between MHCI downregu-
lation and Nef/activated PAK2 complex formation in that
mutation of P69 to alanine does not affect MHCI downre-
gulation [33]. It should be noted that these three Nef
mutants were expressed at levels comparable to the wild
type protein (Figure 4A, Lower Panel), and the V66A
and G67A mutations had no impact on CD4 downregu-
lation while F68A had only a small effect (72.3 ± 3.2% of
SF2Nef activity, See Figure 4B, Upper Panel). From
these results, it is clear that Nef/activated PAK2 com-
plex formation requires the highly conserved residues
just to the N-terminal side of the polyproline helix. Asthese residues are spatially separated from the PQVPLR
binding site, it seems likely that G67, F68 and P69, do not
interact with an SH3 domain, but instead with a differ-
ent region of an SH3 domain containing protein or a
different protein altogether. Spatially close to the three
adjacent amino acids is F90. All of these residues (GFP/
F) are critical for Nef/activated PAK2 complex forma-
tion suggesting that they form an effector domain for
this activity (Figures 2A and 4A and [41]). However,
MHCI downregulation only requires G67 and F68 and
not P69 or F90 (Figures 2B and 4B and [33]).
The impact of the V66A, G67A and F68A mutations
on EVI
The impact on EVI of mutating the three residues to the
N-terminal side of the polyproline helix gave strikingly
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Figure 4 Functional characterization of residues to the N-terminal side of the Nef polyproline helix: V66, G67, and F68. (A), In vitro PAK2
autophosphorylation assays were performed on anti-Nef immunoprecipitates from transfected 293T cells. Upper Panel, Autoradiography shows the
autophosphorylated PAK2 band, indicated by the arrow. Lower Panel, Nef expression was determined by anti-Nef Western blot of whole cell
lysates. One of two experiments is presented. (B), MHCI downregulation and CD4 downregulation by Nefs from (A). Upper Panel, Flow cytometric
analysis of Nef-transduced human CEM T cells was performed to assay cell surface expression of CD4 (x-axis) and MHCI (y-axis). Lower Panel,
Quantitation of MHCI downregulation relative to SF2Nef was set at 100%. Error bars calculated as the mean ± S.E.M. of three independent
experiments. An asterisk indicates a significant reduction in activity relative to SF2Nef.
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complex formation. The V66A mutant retained partial
activity while G67A and F68A were maximally defective
(Figure 5A). As observed for mutations in PQVPLR, the
maximally defective mutations retained residual activity
(Figure 3A). The residual activity may reflect a facilitat-
ing role for Nef in the case of EVI. Again, in the context
of expression from the SF2 provirus the mutant proteins,
V66A, G67A and F68A, were stable (Figure 5B).
Qualitatively similar phenotypes for Nef/activated
PAK2 complex formation (Figures 2 and 4) and EVI
(Figures 3 and 5) suggest interactions by Nef with very
similar SH3 proteins, or even the same SH3 protein for
these activities. It should be noted that, even if Nef uses
the same SH3 protein for Nef/activated PAK2 complex
formation and EVI, the overall mechanisms are nonethe-
less distinct, since EVI is not dependent on Nef/activated
PAK2 complex formation [32,50].PQVPLR, GFP/F, and P78 reside in a region of overlapping,
multifunctional effector domains on the surface of Nef
The spatial relationships between the residues in the
polyproline helix and the surrounding region of Nef are
shown in Figure 6A, Function. PQVPLR is in blue, GFP/
F is in gold (F90), brown (G67 and F68) and tan (P69), P78
and D123 plus nearby highly conserved residues are in
pink; and the hydrophobic pocket containing F90 is in
gold. In HIV-1 subtype B Nefs, only about 45% of resi-
dues are conserved at the 99% level. In Figure 6B, Con-
servation, residues that are labeled and colored green are
99% conserved in HIV-1 subtype B Nefs (L76 is 97% con-
served [32]). The proximity of these amino acids on the
surface of Nef and their extreme conservation are con-
sistent with roles in functionally significant protein-
protein interactions [51].
Each of the colors represents potential multifunctional
interaction domains for Nef binding to cellular proteins.
Figure 5 Impact of V66A, G67A and F68A mutations on Nef-mediated enhancement of virion infectivity. (A), HeLa-MAGI cells were
infected with HIV-1SF2 and HIV-1SF2 with mutant nefs from Figure 4. ΔXho represents HIV-1SF2 with its nef rendered non-functional by filling in the
unique XhoI site with Klenow to make a four base insertion. β-galactosidase positive cells were counted 36 hours post-infection. Viral infectivity
(blue cells per ng p24gag normalized to HIV-1SF2) are presented as the mean ± S.E.M. with n = 6. SF2Nef was set at 100%. An asterisk indicates a
significantly lower value compared to SF2Nef by t test (p< 0.05). Also note that values for all mutated proteins were significantly higher than
ΔXho. (B), Lysates from 293T producer cells for the viruses in (A) were analyzed for Nef and p24gag (p24) expression by Western blot. Equal
amounts of total lysate protein were added to each lane.
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tion. These include the tetra-glutamate segment (resi-
dues E62-E65), G67 and F68. The quadruple mutation of
the tetra-glutamate segment to four alanines has been
reported by many groups to be defective for MHCI down-
regulation [15,19,29,44,45]. The proximity of G67 and F68
to the tetra-glutamate segment suggests concerted action
by these residues in MHCI downregulation.
G67 and F68 are also required for Nef/activated PAK2
complex formation and EVI. P69 is included in this patch
as tan because it contributes to Nef/activated PAK2
complex formation, but not MHCI downregulation.
Gold residues have a role in Hck binding [23,24,38,52].
Here, we report for the first time the importance of F90
for Nef/activated PAK2 complex formation and EVI. Toreflect the overlapping functionalities of its residues we
represented GFP/F in three different colors (Figure 6A).
Blue residues are Nef ’s multifunctional PXXPXR motif,
and pink residues surround P78 and D123 (Figure 6A). D123
is multifunctional and required for MHCI downregula-
tion, EVI and CD4 downregulation [31,32,53]. The conser-
vative mutation D123E is fully defective for these three
Nef activities and enhances Nef/activated PAK2 complex
formation several fold [31,32]. This latter effect may be
related to the fact that mutating the nearby F121 to argin-
ine prevents Nef/activated PAK2 complex formation [20].
D123, P78, T80, and F121 residues are part of a predicted
protein-protein interaction interface [54]. The mechanism
of action of D123 for different functions has remained ob-
scure, although the recent report of the ternary complex
ConservationFunction BA
P69
E65
E64
E63
E62
F68
G67
F90
V70
P72W113
V74
P75
T80
R77
P78
L137
Q73Q118L87
F121
D123
P200
H193
D123, Pink
PQVPLR, Blue
MHCI, Brown
PAK2, Tan
Hydrophobic 
Pocket, Gold
Figure 6 Organization of effector interfaces on the surface of Nef associated with the polyproline helix. (A), Left, Function, The colored
residues are grouped into proposed effector interfaces and presented on the three dimensional surface of Nef. The core of the SH3 domain
binding interface that includes P72, Q73, V74, P75, L76, and R77 is indicated by “PQVPLR, Blue.” A proposed interaction interface important for MHCI
downregulation that includes P78 and D123 is indicated by “D123, Pink”. Two residues near P78 and D123 that are 99% conserved, T80 and F121, are
also pink. A second proposed interaction region important for MHCI downregulation is indicated as “MHCI, Brown.” Brown residues include E62-65
(tetra-glutamate), G67, and F68. The hydrophobic pocket that enhances the affinity of Hck binding includes L87, F90, W113, T117 and Q118 and is
indicated with “Hydrophobic Pocket, Gold.” Note: T117 is obscured in this view. GFP/F is a proposed interface that overlaps “MHCI, Brown” and
“Hydrophobic Pocket, Gold.” PQVPLR and GFP/F act in concert for Nef/activated PAK2 complex formation. GFP/F includes G67 and F68 (brown), P69
(tan), and F90 (gold). “PAK2, Tan” indicates P69 that is not part of the “MHCI, Brown” interface. White residues remain uncharacterized. (B), Right,
Conservation, The same view of Nef as in (A) but the residues that are conserved at 99% in subtype B Nefs are green and labeled. The tetra-
glutamate segment (amino acids 62–65) is conserved in the sense of being a negatively charged patch on the surface of Nef, but none of the
positions is 99% glutamate. Amino acid 87 that is part of the hydrophobic pocket is 96% leucine, 2% isoleucine and 1% methionine [32]. The
modified BH10 Nef (PDB: 2NEF) presented has a truncated N-terminal arm (amino acids 1–55) and has a deletion of the flexible internal loop
(amino acids 159–173). These modifications are not visible as amino acids 56, 158, and 174 are on the backside of this view. All images were
created using Pymol (www.pymol.org).
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D123 in MHCI downregulation [34].
Discussion
Identification of critical amino acids in Nef protein-
protein interaction interfaces
We have carefully mapped by mutational analysis resi-
dues that could possibly act in concert with PQVPLR in
Nef-SH3 domain protein interactions. Mutations were
found that resulted in partial defects, and mutations
were found that eliminated one or more Nef activities.
Mutations of the latter phenotype were observed for
G67, F68, P72, V74, P75, R77, P78, and F90. The mutationalproperties of these residues fit the expected properties of
critical residues in protein-protein interfaces. Typically,
critical residues in protein-protein interfaces exhibit
packing densities equivalent to that found in the inter-
iors of proteins which account for the large disruption of
binding by a conservative replacement or by creating a
hole in the interface with an alanine substitution (glycine
excepted). Further, these critical amino acids are typic-
ally found in the central core of protein-protein inter-
faces [51]. For a given interface only a few of the
residues account for most of the binding affinity, and
identifying these amino acids localizes the interface
[51,55,56].
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For Nef binding to the Hck SH3 domain, four critical
residues (P72, V74, P75, and R77) have been defined by
mutation (Table 1). These four residues engage in mul-
tiple interactions with Hck SH3 amino acids. Numerous
residues that weakly contribute to Nef-Hck SH3 binding
have also been noted [23,24,27,52]. For Nef/activated
PAK2 complex formation, it is the mutation of P72, Q73,
P75 or R77 (but not V74) that gives a total loss of function
phenotype with a similar phenotypic profile observed for
EVI. Therefore, we conclude that the Nef PXXPXR
motif is multifunctional and can bind more than one
SH3 domain protein.
There are overlapping effector surfaces at the N-terminal
end of the polyproline helix
We have defined a new interface, GFP/F, which is neces-
sary for Nef/activated PAK2 complex formation and full
activity of EVI (Table 1). In Figure 6A Function, GFP/F
is presented in three colors with G67 and F68 (brown)
residing between F90 (gold) and P69 (tan). We propose
that GFP/F is part of a protein–protein interaction inter-
face for Nef/activated PAK2 complex formation based
on our mutational analysis and the 99% conservation of
these residues [32]. To test this model we made the con-
servative mutation, F68Y, and we found this mutant NefTable 1 Summary of phenotypes for mutations in the Nef
polyproline region
Residue Hck SH3 PAK2 MHCI EVI CD4
EEEE/AAAA # +1 −1 +1 ++1
V66A # + ++ + ++
G67A # − − − ++
F68A # − − − +
P69A ++3 −3,5 ++6 −5 ++6
P72G − − + − ++
Q73R ++ − ++ + ++
V74I − ++ ++ ++ ++
P75G − − + + ++
L76V ++ + + + ++
R77K − − ++ − ++
P78G ++ + − ++ ++
F90A ++ − + + ++
D123E # ++2,4 −2,4 −4 −2,4
Results are presented from this report unless otherwise indicated. 1Baugh et al.
[29]; 2Kwak et al. [31]; 3Manninen et al. [20]; 4O’Neil et al. [32]; 5Wiskerchen
et al. [41]; 6Yamada et al. [33]. Hck SH3, in vitro binding of Nef to Hck SH3
domain; PAK2, Nef/activated PAK2 complex formation; MHCI, MHCI
downregulation; EVI, enhancement of virion infectivity; CD4, CD4
downregulation. #, indicates that the residue is outside of the known Nef-Hck
SH3 interface [23,24]; “++” activity of mutated protein is >75% of wild type
protein; “+” activity is between 25% and 75% of wild type; “-“ activity is less that
25% of wild type. EEEE/AAAA is the quadruple mutation of the tetra-glutamate
segment (amino acids 62–65) of Nef mutated to four alanines.to be fully defective for Nef/activated PAK2 complex for-
mation (Additional file 2: Figure S2A). The most
straightforward explanation for this result is that F68 is a
critical residue for Nef/activated PAK2 complex forma-
tion engaging in hydrophobic interactions which the
extra hydroxyl group of tyrosine disrupts.
A recently proposed interface overlapping GFP/F is the
secretion modulation region (SMR, spanning V66GFPV70
but not including F90). Bond and co-workers have shown
that secretion of Nef in exosomes and the binding of Nef
to mortalin depends on this motif. In silico modeling sug-
gests the SMR motif forms a protein binding pocket
[57,58]. Therefore, there appear to be at least four Nef
functions modulated by this region of the Nef surface in-
cluding MHCI downregulation, Nef/activated PAK2 com-
plex formation, mortalin binding and EVI but not Hck
binding [59].
A multifunctional surface at the C-terminus of the
polyproline helix
P78 and D123 Nef mutants are defective for MHCI down-
regulation (Table 1). D123 represents a multifunctional
residue as the conservative mutation, D123E, is highly de-
fective for MHCI downregulation, CD4 downregulation
and EVI. A computer analysis of the surface of Nef (PPI-
Pred) included P78 and D123 along with T80 and F121 as
part of a putative protein-protein interaction site [54]. All
of these residues (pink in Figure 6A) are highly conserved
[32]. Further D123 and F121 are part of a proposed
dimerization interface [53,60,61]. This region of the Nef
surface appears to resemble the region at the N-terminus
of the polyproline helix in its multifunctionality.
MHCI downregulation
MHCI is a common target for anti-host defenses of
human viruses. HIV-1 Nef counters MHCI directed
cytoxicity in a distinct mechanism from those of adeno-
virus, human CMV and Kaposi’s sarcoma-associated her-
pesvirus and even simian immunodeficiency virus Nef
[62,63]. Key to HIV-1 Nef ’s mechanism is residue P78.
P78 appears to be specifically involved in MHCI downre-
gulation as mutating P78 to alanine has little or no effect
on other Nef activities (Figures 2, 3 and [20,30,33,41,58].
The recent description of a ternary structure of ctMHCI,
AP-1 μ1 and Nef (http://retroconference.org/2012b/
Abstracts/45450.htm) strongly implies that P78 is critical
for Nef binding and rerouting MHCI away from the cell
surface [34].
An extended stretch of Nef amino acids from E62 to
P78 binds to both AP-1 μ1 and ctMHCI in a manner en-
tirely different from the binding of Nef to SH3 domains
[23,24,34]. In the model of Jia et al., the tetra-glutamate
segment (E62E63E64E65) electrostatically interacts with a
patch of four lysines in AP-1 μ1. This ionic interaction is
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nations of the tetra-glutamate segment mutated to two
glutamates and two alanines all remain functional for
MHCI downregulation [29]. In the new structure, G67
and F68 are part of a bend in the Nef main chain that
allows the polyproline helix to be positioned in the com-
plex near the YXXL binding site of AP-1 μ1. The poly-
proline segment of Nef serves as a clamp over the low
affinity combination of ctMHCI bound to AP-1 μ1.
ctMHCI binds weakly to the YXXL site of AP-1 μ1 be-
cause the cryptic motif in ctMHCI is the defective
YXXA. Down the length of the polyproline segment the
interactions between Nef residues and the complex are
not extensive. Therefore, the structure rationalizes the
partial defects observed with single mutations of
PXXPXR residues while the double mutation of
AXXAXR is fully defective [15,19,29,44,45]. P78 is the
exceptional residue in that it is buried in the ternary
complex. Spatially near P78 is D123, which is also critical
for MHCI downregulation [31,32,53]. D123 forms a salt
bridge with R393 of AP-1 μ1 as part of a network of elec-
trostatic interactions between all three proteins. There-
fore, the model predicts the mutational defects seen in
MHCI downregulation with P78G and D123E.
The ternary complex model originally proposed by
Guatelli and co-workers and Collins and co-workers
[15,18,19,46], has been contested as others have argued
for involvement of SH3 domain host cell proteins, spe-
cifically Hck, Lyn and Src or alternatively a decisive role
for Nef dimerization that is dependent on residue D123
[21,44,53,61]. SH3 domain binding is not part of the
new structure, and the role of D123 in the new structure
excludes it from participating in dimerization.
The structure of Jia et al is a major advance but im-
portant questions remain unanswered [34]. Residue M20
is analogous to P78 in its significance and specificity for
MHCI downregulation (Additional file 2: Figure S2B and
[19,64,65]). Here we have found G67 and F68 to also be
structurally required for MHCI downregulation. These
Nef residues may be involved in binding additional fac-
tor(s) to the Nef effector complex for MHCI downregu-
lation [46].
Analysis of the in vivo significance of Nef activities
Detailed characterization of Nef protein-protein inter-
action interfaces makes feasible targeted studies of the
impact of Nef activities on HIV-1 replication and cyto-
toxic impact in vivo. BLT humanized mice represent an
advanced model for reconstitution of the human im-
mune system [66-68]. We have recently published the
complex phenotype of nef(-)HIV-1 in this system of
reduced viral replication and highly cytotoxic effects on
T cells and thymocytes [69]. Significance for a given Nef
activity can be established by mutations specific for thatfunction that result in either reduced HIV-1 replication/
cytotoxicity or rapid reversion of the mutation.
It should also be noted that a second recent report inves-
tigated the three amino acid loop, V66, G67, and F68 [70].
Mutations of these amino acids resulted in defects for
MHCI downregulation, Nef/activated PAK2 complex for-
mation, EVI but not CD4 downregulation. In addition, the
Nef activities of inhibition of actin remodeling following T
cell receptor stimulation, hyper-phosphorylation of cofilin
and CXCR4 downregulation were dependent on the loop
residues.
Conclusions
We have undertaken detailed mutational analysis of poly-
proline helix and proximal surface residues that are critical
for multiple Nef activities. Four of the Nef activities that
have been suggested to be dependent on host cell SH3 do-
main proteins have been investigated. We have demon-
strated that three Nef activities, Nef/activated PAK2
complex formation, Hck binding and EVI are dependent
on a Nef-SH3 domain protein interaction. When subjected
to detailed analysis a fourth activity, MHCI downregula-
tion, does not exhibit the properties expected of an activity
dependent on an SH3 domain protein. Particularly telling
in this regard is the small impact of the R77K mutation on
MHCI downregulation. Furthermore, the three Nef activ-
ities that definitely require SH3 domain proteins do not de-
pend on the same host cell protein. Hck and at least one
additional SH3 domain protein interact with Nef.
The functionally dense region of the Nef surface investi-
gated here serves as a model for the protein’s structural
complexity. The stretch of amino acids from E62 to P69 plus
the spatially close F90 contains at least four combinations of
residues that effect separate Nef activities-Nef/activated
PAK2 complex formation, EVI downregulation, MHCI
downregulation, and mortalin binding. From P72 to R77,
PQVPLR acts as a PXXPXR motif to bind at least two dif-
ferent SH3 domain proteins and contributes to MHCI
downregulation. Near the C-terminal end of the polypro-
line helix D123 is involved in at least three different Nef ac-
tivities [31,32]. For MHCI downregulation, D123 acts in
conjunction with P78 to pin the ctMHCI to AP-1 μ1. The
rest of the polyproline segment plays a supporting role in
ternary complex by positioning the tetra-glutamate seg-
ment to interact with a lysine patch on AP-1 μ1.
Maintenance of the structure of this critical region of
Nef enforces strict conservation of the component resi-
dues and implies that the associated activities confer fit-
ness to the virus. Extending the type of analysis presented
here to the rest of the Nef surface will define which Nef
activities are sufficiently important to structurally impose
overlapping protein-protein interaction interfaces and the
attending extreme conservation of amino acid residues.
Detailed functional analysis will allow activity-specific
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Highly conserved protein-protein interaction interfaces
for significant Nef activities would then be preferred tar-
gets for developing drug-like inhibitors of Nef function
[71].
Methods
Cell lines and culture conditions
Human CEM Tcells were cultured in RPMI 1640 medium
supplemented with 10% fetal bovine serum (Hyclone), 50
IU of penicillin per ml, 50 μg streptomycin per ml, 2 mM
L-glutamine and 1 mM sodium pyruvate. HEK 293T cells
were cultured in DMEM with 10% fetal bovine serum, 50
IU of penicillin per ml, 50 μg/ml of streptomycin and 2
mM L-glutamine. HeLa-MAGI cells were cultured in the
presence of 1.0 mg/ml puromycin. Cell lines were main-
tained at 37°C in a humidified incubator with 5% CO2
(CEM) or 10% CO2 (293T and HeLa-MAGI).
Plasmid DNA constructs
The pcDNA3.1-SF2Nef plasmid DNA expression vector
was utilized for transient transfection of 293T cells. Bac-
teria expression vectors were pGEX2TSF2Nef which
expresses full length Nef as a GST fusion protein and
pET28aHckSH3 which expresses amino acids 61–117 of
Homo sapiens Hck (gi:56203176) in frame with polyhis-
tidine. The pLXSN, pLNefSNSF2 (wild type or mutated),
and pEQPAM vectors were transfected into HEK 293T
cells to generate amphotropic vectors for subsequent
transduction of CEM T cells. The p9B18 HIV-1SF2 pro-
viral clone was transfected into HEK 293T producer
cells to generate infectious virus for HeLA-MAGI infect-
ivity assays. Point mutations were made by site-directed
mutagenesis in SF2Nef as previously described [72]. All
mutations were verified by DNA sequencing and are
numbered in accordance with the standard Nef length of
206 amino acids.
Transfection of HEK 293T cells
One day prior to transfection, HEK 293T cells were plated
at 800,000 cells per well in six-well plates such that the
cells would be 90% confluent upon transfection. The
pcDNA3.1, pcDNA3.1-SF2Nef, p9B18-SF2, pLXSN and
pEQPAM plasmid DNA vectors were transfected into the
cells using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. Four hours post-transfec-
tion, the culture medium was replaced with fresh DMEM
with 10% fetal bovine serum and antibiotics. 36–48 hours
post-transfection, cell lysates and/or virus supernatants
were harvested for subsequent experiments.
Transduction of human CEM T cells
pEQPAM (2 μg) and pLNefSNSF2 (2 μg) were co-
transfected into HEK 293T cells to generate amphotropicvirus as described above. Harvested viral supernatants
were filtered through 0.45 μm filters. 24-well plates were
coated with 400 μg of Retronectin (Takara) followed by
500 μl of 2% bovine serum albumin in phosphate buffered
saline. Wells were then rinsed and virus was absorbed
upon incubation with 500 μl of virus supernatant twice at
one-hour intervals. CEM T cells (300,000 per well) were
incubated overnight. The next day, a third addition of 500
μl of viral supernatant was added on top of the cells.
Twenty four hours later, cells were collected, washed and
re-suspended in complete RPMI containing 1.5 mg/ml
G418 for selection. Cells were expanded into T-75 cm2
flasks, at which point the cells were harvested for subse-
quent Western blot analysis, in vitro kinase assay, and
flow cytometric analysis.
Western blot analysis and antibodies
Cells were washed in phosphate-buffered saline and
lysed in 1 ml of Buffer A (50 mM Tris, pH = 8.0, 100
mM NaCl, 25 mM NaF, 25 mM benzamidine, 20 mM
β-glycerophosphate, 2 mM Na3VO2, 3 mM EDTA, 10%
glycerol, and 0.5% IGEPAL-630) containing one Roche
protease inhibitor tablet per 10 ml. Lysates were centri-
fuged at 13,000 X g for 30 minutes and the supernatant
fraction was prepared for SDS-PAGE gel electrophoresis.
Separated proteins were transferred to nitrocellulose.
The transferred blots were blocked with 10% milk and
subsequently incubated with primary antibodies for one-
hour at room-temperature, washed, and probed with
HRP-conjugated secondary antibodies. Western blots
were visualized by chemiluminescence upon incubation
with luminol and p-coumaric acid. Nef protein expres-
sion was determined using the sheep polyclonal anti-
SF2Nef serum, as previously described [32,72].
In vitro kinase assay
Endogenous Nef/activated PAK2 complex formation assays
were performed as previously described [32,72]. Nef-
expressing 293T cells were lysed in Buffer A containing one
Roche protease inhibitor tablet per 10 ml. Lysate containing
600 μg of protein was completely immunoprecipitated with
10 μl sheep anti-SF2 Nef serum and protein A agarose
beads (Sigma) [39]. In one experiment (Additional file 1:
Figure S1A), 10 μl of anti-PAK2 antibody (Cell Signaling)
was used. Protein A beads were washed twice in lysis buffer,
once in 1M MgCl2, and twice in kinase buffer (10 mM Tris,
pH = 7.5, 5 mM MgCl2 and 1% Triton X-100). The beads
were then resuspended in 100 μl of kinase buffer. γ-[32P]-
ATP was incubated with the immunoprecipitates for 10
minutes at room temperature. The kinase reaction was ter-
minated upon addition of EDTA. Proteins were eluted with
SDS Laemmli buffer and resolved by 9% SDS-PAGE. Phos-
phorylated proteins were quantitated by phosphoimager
analysis (Packard Cyclone). In Additional file 1: Figure S1B,
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myelin basic protein phosphorylation was performed in
identical fashion to the autophosphorylation assay except
that 15 μg of myelin basic protein were added to the 0.1 ml
autophosphorylation reaction.
Flow cytometry analysis
For analysis of cell surface CD4 and MHCI levels, trans-
duced CEM cells (500,000) were first incubated with
mouse monoclonal anti-haplotype A1, A11, and A26
MHC class I antibody (One Lambda) for 20 minutes on
ice and then washed. Cells were then incubated with
fluorescein isothiocyanate (FITC)-labeled rabbit anti-
mouse IgG for 20 minutes on ice and then washed. Cells
were then incubated with 2 μg of mouse IgG for 20 min-
utes on ice and then washed. Cells were then incubated
with phycoerythrin (PE)-conjugated IgG1 monoclonal
antibody to human CD4 (Exalpha) for 20 minutes on ice
and then washed. Stained cells were analyzed on a BD
FACSCalibur instrument equipped with CellquestPro
software. CEM cells transduced with LXSN served as
the positive control. For negative controls mouse isotype
antibody replaced anti-MHC class I, and PE-conjugated
mouse IgG1 (Exalpha) replaced PE-conjugated anti-CD4.
HeLa-MAGI infectivity assays
As described above, HEK 293T cells were transfected with
the proviral clone for SF2 (p9B18) to generate infectious
virus. Virus was harvested 48 hours post-transfection, fil-
tered through a 0.45-μm filter, and stored frozen in ali-
quots at −70°C. The virus produced was normalized by
p24gag ELISA. HeLa-MAGI cells (80,000) were plated in
12-well plates and infected 24 hours later in triplicate with
5 ng of p24gag of virus in 400 μl of cell culture medium
containing 20 μg/ml of DEAE-dextran (Sigma) at 37°C.
After a two-hour incubation, fresh culture medium was
added, and the cells were incubated for an additional 36
hours. The cells were then fixed and stained with X-gal.
Blue cells were counted as indicators of infected cells. Ex-
pression of Nef and p24gag in lysates of 293T producer
cells was analyzed by Western blot analysis as described
above.
In vitro binding assay
BL-21 pLysS bacteria were transformed with pGEX4T,
pGEX2TSF2Nef, pGEX2TSF2NefP72G, pGEX2TSF2NefQ
73R, pGEX2TSF2NefV74I, pGEX2TSF2NefP75G, pGEX2T
SF2NefL76V, pGEX2TSF2NefR77K, pGEX2TSF2NefP78G,
pGEX2TSF2NefF90A, and pET28HckSH3 (Hck amino
acids 61-117). The fusion protein derived from
pGEX2TSF2Nef has been previously shown to bind the
SH3 domain of Hck in pulldown assays [29]. A 10 ml
starter culture in Luria-Bertani medium with 34 μg/ml
chloramphenicol and either 50 μg/ml of ampicillin(pGEX construct) or kanamycin (pET28 construct) was
initiated from a single colony, grown at 37°C 225 RPM, and
used to inoculate 250 ml of Luria-Bertani medium with
antibiotics as described previously [29]. The 250 ml culture
was grown at 37°C, 225 RPM until optical density at 600
nm reached 0.6. Isopropyl-ß-D-thiogalactopyranoside was
added to the culture to a final concentration of 3 mM and
allowed to induce for 3 hours shaking at 37°C and 225
RPM. Bacteria were pelleted and stored frozen at -20°C.
Bacteria pellets containing glutathione S-transferase
(GST) fusion proteins or histidine (His) tagged protein
were resuspended in 15ml of PBS containing one tablet of
Roche protease inhibitor per 10 ml. The resuspended bac-
teria were sonicated on ice using a microtip for 1 minute
at power level 3.5; 10s on and 10s off. Bacterial lysates
were centrifuged at 10,500 RPM, 4°C, 20 minutes. Super-
natants of GST fusion proteins were rotated with 0.5 ml
packed glutathione Sepharose beads (GE Healthcare) for
30 min at room temperature on a rotator. His-tagged pro-
tein was incubated with 0.5 ml packed HisPur Cobalt
Resin (Pierce) for 30 minutes at 4°C on a rotator. At 4°C,
the Sepharose beads were washed with 10ml cold PBS
three times, and HisPur cobalt resin was washed with 6ml
HisPur wash buffer (50 mM sodium phosphate, 300 mM
NaCl, and 10 mM imidazole) three times. The bound
GST fusion protein was eluted with 20 mM reduced gluta-
thione pH 8.0, and the bound His-tagged protein was
eluted with HisPur elution buffer (50 mM sodium phos-
phate, 300 mM NaCl, 150 mM imidazole). Concentration
of all proteins was determined by Bradford; purity was
determined by SDS-PAGE electrophoresis; and each pro-
tein was exhaustively dialyzed in binding buffer (50 mM
Tris pH7.5, 1% IGEPAL CA-630, 2 mM MgCl2, 200 mM
NaCl and 5 mM ß-mercaptoethanol). Binding assays with
proteins at 3 μM were performed as described previously
[29] and analyzed by Western blotting with polyclonal
anti-polyhistidine (Abcam).Additional files
Additional file 1: Figure S1. Activated PAK2 cannot be detected in
293T cells without Nef expression. (A), Upper Panel, The
autophosphorylation activity of SF2Nef was determined as in Figure 2
except that PAK2 was directly immunoprecipitated by anti-PAK2
antibody. The autophosphorylated band of PAK2 is indicated by an
arrow. Vector control not expressing SF2Nef is indicated by “pcDNA.”
Note the total absence of activity in the control cells without Nef. Lower
Panel, Anti-Nef Western demonstrating expression of SF2Nef. (B), The
in vitro kinase assay was performed on anti-Nef immunoprecipitates with
the sole modification that 15 μg of myelin basic protein was added to
the assay. Upper Panel, PAK2 is the autophosphorylated PAK2 protein, and
MBP is the phosphorylated myelin basic protein. Middle Panel, Coomassie
blue stain of MBP in the reaction. Lower Panel, Anti-Nef Western blot
demonstrating expression of SF2Nef.
Additional file 2: Figure S2. Nef/ activated PAK2 complex
formation is defective for SF2NefF68Y but wild type for
SF2NefM20A. (A), Upper Panel, The activities of SF2Nef and the four
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autophosphorylated band of PAK2 is indicated by an arrow. Vector
control not expressing SF2Nef is indicated by “pcDNA.” Lower Panel, Anti-
Nef Western demonstrating equal expression of SF2Nef and the mutated
proteins. (B), Same as in (A) for vector control, SF2Nef and SF2NefM20A.
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